Threshold Ventures is a Palo Alto-based venture capital firm that invests across software, consumer, enterprise, and healthcare technology. It is a broad technology investor rather than a dedicated healthcare or neurotechnology specialist. Its current identity is much more generalist than thesis-driven around brain health.

While it has healthcare exposure, its orientation is more toward scalable technology businesses than regulated neurodevices or neuroscience therapeutics. That means it may be relevant to neurotech companies with strong software, data, or platform characteristics, but it is not a clear sector specialist. It is best treated as adjacent rather than core for most neurotech fundraising strategies.

The firm focuses primarily on the United States. For neurotech founders, Threshold is more likely to be useful for software-heavy or digital platform businesses than for deep neuroengineering or clinical neurotechnology. It is not a priority specialist fund, but it may fit certain tech-led models.